About
Jeremy O’Connell, PhD is the Chief Scientific Officer and co-founder of Juvena Therapeutics, a biotech company developing regenerative biologics for chronic and age-related diseases. Juvena says he oversees research strategy, pre-clinical science, manufacturing, and intellectual property, drawing on training at UT Austin, Harvard Medical School, and Stanford. Public reporting describes him as a scientific co-founder focused on proteomics, systems biology, and AI-enabled drug discovery rather than as an investor or fund manager.
Areas of interest
longevitybiotechregenerative medicineproteomicssystems biologyAI-enabled drug discoveryneuromuscular diseaseage-related diseases